Clinical and Ophthalmological Findings in Patients with Behçet’s Uveitis at First Presentation
Journal of Comprehensive Surgery · 2023
DOI: 10.51271/jocs-0006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Comprehensive Surgery, 2023. Verfasst von Eyüpcan Şensoy und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
The present study attempted to demonstrate the clinical, demographic, and ophthalmological findings of patients with Behçet’s disease (BD) at first admission and relevant treatment modalities.
Methods
We considered 161 eyes of 103 patients applying to the Uvea Unit of Ulucanlar Eye Training and Research Hospital between 2000-2012 and already suffering from BD or diagnosed with BD at their follow-ups. Then, we retrospectively investigated their clinical, demographic, and ophthalmological findings at first admission and the treatment modalities with the help of their medical records.
Results
There were 70 (68%) male and 33 (32%) female patients, and 17 patients (16.5%) initially presented with ocular symptoms. While the patients’ mean diagnosis age was 26.79±9.24 years (4-61 years), it was 29.52±9.49 years (6-62 years) at the first eye attack. Eye involvement was bilateral in 58 patients (56.3%) and unilateral in 45 (43.7%). About half of the eyes (55.9%) were presented as panuveitis, 22.4% as posterior uveitis, 15.5% as anterior uveitis, and 6.2% as intermediate uveitis. While there were anterior chamber reaction + vitritis + retinitis and/or vasculitis (panuveitis) in 90 (55.9%) eyes, the others were characterized by isolated retinitis (12.4%) and isolated iridocyclitis (8.7%). Only two eyes (0.1%) had hypopyon at admission. We discovered at least one complication in 111 eyes (68.9%) at first admission. In particular, the most prevalent complication was found to be isolated macular edema in 45 eyes (28%) and isolated cataracts in 17 eyes (10.6%). On the other hand, topical steroid + systemic steroid + immunosuppressive (23.6%), topical + systemic steroid (16.8%), and systemic steroid + immunosuppressive (11.8%) became the most prevalently adopted medical treatments (with additions/alterations) at first admission, respectively.
Conclusion
In a nutshell, BD is considered a multisystemic condition with frequent ocular manifestations. BD-associated uveitis often presents as panuveitis. Thus, early and efficient treatment of ocular complications seems to be critical for better visual prognosis.
Zitieren
APA
Şensoy, E., Turan, O., Çıtırık, M., & Berker, N. (2023). Clinical and Ophthalmological Findings in Patients with Behçet’s Uveitis at First Presentation. Journal of Comprehensive Surgery. https://doi.org/10.51271/jocs-0006
Vancouver
Şensoy E, Turan O, Çıtırık M, Berker N. Clinical and Ophthalmological Findings in Patients with Behçet’s Uveitis at First Presentation. Journal of Comprehensive Surgery. 2023. doi:10.51271/jocs-0006
BibTeX
@article{ensoy2023,
author = {Şensoy, Eyüpcan and Turan, Oğuzhan and Çıtırık, Mehmet and Berker, Nilüfer},
title = {Clinical and Ophthalmological Findings in Patients with Behçet’s Uveitis at First Presentation},
journal = {Journal of Comprehensive Surgery},
year = {2023},
doi = {10.51271/jocs-0006}
}
EUVIMED